精液质量差的男性家庭成员儿童期死亡风险研究
该回顾性队列研究纳入12889名接受精液分析的男性及其79750名兄弟姐妹和160016名姑叔舅姨,发现精液分析男性亲属与 fertile 对照组相比,全因儿童期死亡风险无显著差异(女性HR=1.08,男性HR=0.88);但精液质量较差者尤其无精子症男性的一级亲属先天畸形相关死亡风险升高(HR=2.69)。
要点
- 精液分析男性一级亲属全因儿童期死亡风险与 fertile 对照组无显著差异(女性HR=1.08,95%CI 0.88-1.32;男性HR=0.88,95%CI 0.75-1.04)。
- 精液质量与一级或二级亲属儿童期癌症死亡风险无关联(HRFDR=0.98,HRSDR=1.12)。
- 无精子症男性一级亲属先天畸形相关死亡风险升高(HR=2.69,95%CI 1.24-5.84)。
核心结论
- 不育与子代先天畸形的关系复杂,精液参数较差男性的一级亲属先天畸形相关死亡风险升高,但二级亲属无此现象。
- 研究提示先天缺陷风险增加可能并非源于辅助生殖技术,而源于联系不育与出生结局的遗传或环境因素。
研究设计与样本
- 回顾性队列研究,数据来自Subfertility, Health and Assisted Reproduction研究(队列构建于1996-2011年)并与犹他州人口数据库(UPDB)关联。
- 指数病例为12889名接受精液分析且家族与随访数据完整的男性,精液参数包括精液浓度、精子计数、活力、总活动计数、精子头部形态、精子尾部形态和存活率。
- 精液分析数据来自两家三级医疗中心男科实验室,自2004年以来覆盖犹他州约90%的精液分析。
- 选取年龄和性别匹配的 fertile 对照作为比较组,共纳入79750名兄弟姐妹和160016名姑叔舅姨,评估家族儿童期死亡聚集性。
主要发现
- 精液分析男性队列中,一级亲属发生406例(1.0%)死亡,二级亲属发生772例(1.1%)任何原因死亡。
- 精液分析男性亲属与 fertile 对照组相比,全因儿童期死亡风险无显著差异(女性HR=1.08,95%CI=0.88-1.32;男性HR=0.88,95%CI=0.75-1.04)。
- 精液质量与一级或二级亲属儿童期癌症死亡风险无关联(HRFDR=0.98,95%CI=0.62-1.54;HRSDR=1.12,95%CI=0.83-1.50)。
- 精液分析男性一级亲属平均随访19.71年, fertile 对照组一级亲属平均随访19.73年;随访期间精液分析男性一级亲属先天畸形相关死亡未调整相对风险增加40%。
- 按精液参数分层并调整出生年份后,精液质量较差男性尤其无精子症男性的一级亲属先天畸形相关死亡风险更高(HR=2.69,95%CI=1.24-5.84)。
局限性
- 研究中较大比例精液分析男性精液参数正常,这些男性本人可能并不不育,但夫妇层面可能不育(即女性伴侣可能不育)。
- fertile 男性样本未进行精液测量,解释结果时需谨慎。
- 无法纳入潜在混杂因素如内科合并症、吸烟状态或环境暴露。
- 精液分析男性来自犹他大学或Intermountain Health Care诊所的生育评估,提示为更选择的人群。
- 因世界卫生组织正常活力阈值在研究期间多次变更,研究将形态分类为等分布四分位数。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: What is the familial childhood mortality in first-degree (FDR) and second-degree relatives (SDR) of patients undergoing semen analysis (SA)? SUMMARY ANSWER: The relationship between infertility and congenital malformations (CM) in offspring is complex, with an increased risk of death due to CM in FDR, but not SDR, of men with lower semen parameters. WHAT IS KNOWN ALREADY: Semen quality is an established predictor of men's somatic health. We can gain a better understanding of possible genetic or environmental determinants of the infertility phenotype by exploring familial aggregation of childhood mortality in relatives of men with poor semen quality. STUDY DESIGN, SIZE, DURATION: Retrospective cohort study from the Subfertility, Health and Assisted Reproduction study (cohort compiled 1996-2011) linked with patient/familial information from the Utah Population Database (UPDB). Index cases included a clinic-referred sample of 12 889 men who underwent SA and had adequate familial and follow-up data in the UPDB. Parameters of semen quality included: semen concentration, sperm count, motility, total motile count, sperm head morphology, sperm tail morphology and vitality. PARTICIPANTS/MATERIALS, SETTING, METHODS: SA data were collected from two tertiary medical center andrology laboratories that have captured ~90% of all SA performed in Utah since 2004. Age- and sex-matched fertile controls were selected to create the comparison group for determining risk of childhood death (to age 20 years) in family members. A total of 79 750 siblings and 160 016 aunts/uncles were used to investigate the familial aggregation of childhood mortality. The main outcome was childhood mortality in FDR and SDR of men with SA and their matched controls. All-cause and cause-specific Cox proportional hazard models were used to test the association between semen quality and childhood mortality in family members. Cause-specific models were considered for cancer and CM. MAIN RESULTS AND THE ROLE OF CHANCE: In the cohort of men with SA, there were 406 (1.0%) deaths in FDR and 772 (1.1%) deaths in SDR due to any cause. There was no significant difference in the risk of all-cause childhood mortality between the relatives of men with SA and the fertile control group [hazard ratio (HR)Female = 1.08, 95% CI = 0.88, 1.32; HRMale = 0.88, 95% CI = 0.75, 1.04]. We found no association between semen quality and risk for childhood cancer mortality in FDR or SDR (HRFDR = 0.98, 95% CI = 0.62, 1.54; HRSDR = 1.12, 95% CI = 0.83, 1.50). The FDR of men with SA and fertile controls were followed on average for 19.71 and 19.73 years, respectively. During this period of follow-up, FDR of men with SA had an unadjusted 40% relative risk of increased CM-related death. After stratifying by semen parameters and adjusting for birth year, we found FDR of men with worse semen quality, and notably azoospermic men (HR = 2.69, 95% CI = 1.24,5.84), were at higher risk of CM-related death. LIMITATIONS REASONS FOR CAUTION: A large proportion of men with SA in the study had normal semen parameters. It is important to note that these men themselves may not be subfertile, but they were subfertile at the couple level (i.e. the female partner may be infertile). In addition, care is needed when interpreting our results, as we do not have semen measures on our sample of fertile men. Second, we were unable to include potential confounders such as medical comorbidities, smoking status, or environmental exposures. Third, men with SA were seen at the University of Utah or Intermountain Health Care clinics for a fertility evaluation thereby suggesting a more select population. Fourth, we chose to categorize morphology into equally distributed quartiles as a response to the fact that the World Health Organization threshold for normal motility changed multiple times during our study period. Lastly, we do not know the proportion of female partners with diagnosed infertility. We chose not to subcategorize each infertile male by infertile diagnosis because our goal was to understand how semen parameters influenced familial childhood mortality. WIDER IMPLICATIONS OF THE FINDINGS: We are not the first study to show a relationship between fertility and CMs. Children conceived through ART may be at higher risk of birth defects, however it is not known if the relationship is causal or if there is some underlying factor linking infertility and birth outcomes. This study provides further evidence that the increased risk of congenital birth defects may not be due to the ART, but rather genetic or environmental factors that link the two outcomes. We encourage further research in order to confirm a relationship between semen quality and increased risk for CM. STUDY FUNDING/COMPETING INTERESTS: This work was supported by the National Institutes of Health - National Institute of Aging [Grant numbers 1R21AG036938-01, 2R01 AG022095 and 1K12HD085852-01]. Authors have no competing interests to disclose. TRIAL REGISTRATION NUMBER: Not applicable.
引用
- Hanson HA, Mayer EN, Anderson RE, et al. Risk of childhood mortality in family members of men with poor semen quality. Hum Reprod. 2016. PMID: 27927843
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。